A Sept. 13 Herb on TheStreet column,

Silicon Labs' Confounding Customer List, mistakenly reported that

Spectrian

(SPCT:Nasdaq) had failed to disclose the

SEC

was reviewing its 10-K filing. In fact, Spectrian said July 16 that its 10-K was part of a "routine in-process review" by the agency.